C vs SKYE · P/E 16, rev $85.22B vs $25.0M cap
Citigroup Inc. (C) versus Skye Bioscience, Inc. Common Stock (SKYE) — a side-by-side from cached financials, not a winner call.
Citigroup Inc. (C) is a banks - diversified company listed on US.
Skye Bioscience, Inc. Common Stock (SKYE) is a biotechnology company listed on NASDAQ.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
SKYE does not have a complete income-statement cache yet.
C currently screens at market cap $214.73B and trailing P/E 15.5. SKYE currently screens at market cap $25.0M.
Not investment advice. Open the C and SKYE stock pages for the full models.
Not investment advice.